Mergers, tender offers, buyouts and asset sales involving Japanese companies, in English.
SoftBank Group paid the last $10bn of its $30bn OpenAI top-up on October 1 with senior bond proceeds, taking cumulative investment to $64.6bn and its stake to about 13%, and cancelled $10bn of undrawn bridge capacity.
SBI Insurance Group would be delisted on 30 March 2027 as planned, with each of its shares converting into 3.53 SBI Global Asset Management shares, but the ratio can change and a final agreement, votes and approvals are still needed.
Tsukishima Holdings shareholders would receive 0.88 Mitsubishi Kakoki shares each under an April 2027 plan that ends in a single holding company; both sets of shareholders are scheduled to vote on December 4.
Media Do will sell Quality Solutions, NetGalley and three subsidiaries to Valsoft for $20mn, about ¥3.15bn, and expects a special gain in the quarter to November 2026 that it has not yet quantified.
Kyorin Pharmaceutical has signed to sell its generics subsidiary, including the Takaoka and Inami plants, to a venture owned by Daito, Meiji Seika Pharma and DBJ, with closing planned for April 1, 2027 and authorized generics carved out.
K.R.S.Corporation paid ¥2.85bn in cash for 51.6% of Indian cold-chain operator Coldrush, completed on 1 September, as rising transport, warehouse and labour costs trimmed its nine-month operating profit by 1.0%.
Kokuyo's board has approved a ¥28bn capital increase in its Singapore acquisition vehicle to pay for Thien Long shares, but the injection depends on approval from Vietnamese authorities and has no date.
Japan Display expects a ¥51.4bn consolidated gain from selling its idled Mobara plant to a Nagano-based manufacturer, but the price is withheld at the buyer's request and handover is scheduled for 31 March 2027.
Fitcrew's board approved a ¥456mn cash purchase of five VALX GYM sites, planned to complete on November 1, while VALX's planned purchase of Fitcrew shares has no set size or timing.
FIDEA Holdings' Yamagata and Akita banks signed their merger contract on 30 September, with the merged The FIDEA Bank, Ltd. planned for 1 January 2027 subject to regulatory approvals; the company said its earnings forecast is unaffected.
Chiba Bank and Chiba Kogyo Bank have finalised a one-for-one common-share swap into Chiba Financial Group, planned for 1 April 2027, subject to a 23 December shareholder vote and regulatory approvals including one under the Banking Act.
SBI Holdings' offer vehicle lengthened its ¥340-a-share bid for BASE from 20 to 30 business days after reviewing how holders had tendered, with the 20.67% ceiling and BASE's neutral stance untouched.
Agent IG Holdings completed its purchase of part of Advance Create's insurance book on 30 September, listing 44,680 non-life and 153,665 life contracts as the targets under the final contract, with the price withheld under a confidentiality obligation to the seller.
NTT DATA has signed to buy 2,392,900 Minkabu shares at ¥900 each, taking its holding to 16.38%, with the right to nominate one director and consent rights over dilutive issues and rival tie-ups; settlement is scheduled for December 15.
Both boards voted on 29 September to cancel their February integration memorandum after failing to agree terms, and Kanadevia now expects to publish its next medium-term plan around spring 2027.
Kamgras raised its Kakaku.com offer to ¥3,681 a share from ¥3,680 and extended the tender to October 14, saying a rival's ¥3,597 notice cannot be completed while its own offer runs.
Japan Lifeline plans to pay up to $4.73mn, including a $4mn earn-out, for Cross Vascular, an FDA-cleared developer with no revenue reported for 2023 to 2025, and to inject another $7.27mn to pay its debts and fund operations.
IHI will sell all of Steinmüller Engineering to a Mutares subsidiary in mid-October, expecting about ¥14bn in consolidated other expenses and a ¥17bn standalone loss, with the sale price undisclosed and its full-year forecast unchanged.
Crasus Chemical is now trading in Tokyo, and Resonac expects its October 1 share distribution to leave it with 18.57%, so the petrochemicals unit drops out of both consolidation and equity-method accounting.
Amvis Holdings is splitting off 47 western Japan hospice homes and has agreed to sell them to an NSSK-backed buyer for a combined ¥17.4bn, refocusing its remaining hospice network on high-acuity, end-of-life patients around Tokyo and eastern Japan.
A Blackstone-affiliated TechnoPro vehicle, TX1 Kabushiki Kaisha, wants to take Project Holdings private at ¥2,200 a share, a price it raised twice after the target's independent committee rejected two lower offers, and investors holding almost 60% of the stock have already agreed to sell.
Japan's SBS Holdings has signed to buy all of Mitsubishi Chemical Logistics from its parent for ¥19.2bn in share consideration, plus advisory costs, bringing the estimated total to ¥19.35bn subject to adjustment at closing, as the target's earnings flipped into a ¥1.07bn net loss, with completion pending regulatory approval and due April 1, 2027.
Smaregi will absorb the register-cloud and cashless-payment customers of Casio subsidiary CXD Next for a token ¥1, using the years before the net-POS business's scheduled 2029 shutdown to pitch them on switching platforms.
Hulic Reit plans to exchange three ageing Tokyo properties for a 24.99% stake in a newly built Osaka luxury tower and separately buy a Koto-ku office building, both from its sponsor Hulic Co., and has decided to borrow ¥21.2bn from Mizuho and MUFG Bank to help fund the deals.